久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Is Avoidable Experiment Expenditure Draining Billions from COVID-19 Research? fiercepharma
    August 26, 2020
    The rise of COVID-19 represents an unprecedented situation for pharma. With the scramble to find a vaccine, R&D productivity is more important than ever, which makes it especially concerning that pharma still struggles with a widely recognized productivit
  • Pharma R&D productivity hits new low amid rising costs pharmaphorum
    December 20, 2018
    Returns on pharma R&D investment are at a nine-year low, and the cost of developing a drug has nearly doubled since 2010, according to Deloitte’s yearly assessment of the industry’s pipeline productivity.
PharmaSources Customer Service